Clinical trials recruiting in Richmond, Australia

Phase breakdown

Conditions recruiting in Richmond, Australia

Recruiting trials in Richmond, Australia

• A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
  NCT07522073 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
  NCT06867094 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Pancreatic Cancer Early Detection Consortium
  NCT04970056 · Phase: Not specified · Ages: 18 Years to 90 Years · Sex: All (male and female)
• Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
  NCT05093231 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• The EXCEL Registry of Patients Requiring ECMO
  NCT03793257 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Richmond, Australia?

5 recruiting trials have at least one study site in Richmond, Australia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.